จดัการ (อังกฤษ) : TISCO Biotechnology Healthcare Fund 1.3. ช่ือยอ่ : TBIOTECH 1.4. ประเภทโครงการ : กองทุนเปิด 1.5. ประเภทการขาย : ขายหลายครั้ง 1.6. การก าหนดอายุโครงการ : ไม่ก าหนด 1.7. อายุโครงการ : ปี
องทนุรวม : 1.1. ชือ่โครงกำรจัดกำร (ไทย) : กองทนุเปิด ทสิโก ้ไบโอเทคโนโลย ีเฮลธแ์คร ์ 1.2. ชือ่โครงกำรจัดกำร (องักฤษ) : TISCO Biotechnology Healthcare Fund 1.3. ชือ่ยอ่ : TBIOTECH 1.4. ประเภทโครงกำร
2018 and for the full year in 2019. The advantages of Figure 2: IVL’s Business Profile Figure 3: Margins and Returns Note: Core Financials, all ratios are based on US$ calculation Note: Core EPS for 2013
2018 and for the full year in 2019. The advantages of Figure 2: IVL’s Business Profile Figure 3: Margins and Returns Note: Core Financials, all ratios are based on US$ calculation Note: Core EPS for 2013
Thailand has advantages in terms of quality of medical organizations, treatment success rate, and reasonable costs. The Company and its affiliated hospitals strive to improve quality, product diversity, and
, lease or transfer the right in real estate to the REIT in a manner that causes the trustee to be unable to independently perform its duties relevant to real estate or taking advantages from real estate
sustainable advantages for the longer term. These include signing off on a single source of truth with ONE ERP across our businesses, setting up a global shared services center in India, taking a deep dive into
. Project Olympus is on track and will bring in US$76M run rate cost savings in 2020. We decided to remain focused on our 5 strategic priorities as these will help us build sustainable advantages for the
and wellness tourism, agriculture and biotechnology, robotics, aviation and logistics, biofuels and biochemical, digital, and medical hubs. The promotion of these industries comes with investment
work process, increase work efficiency and obtain the competitive advantages over competitors. For instance, EGCO arranged innovation workshopped to encourage the process of innovative thinking to